Clinical Trials on Gland; Functional Disturbance in Japan

Total 865 results

Zeria Pharmaceutical

Completed

To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia

Functional Dyspepsia

Japan
United States Naval Medical Center, San Diego

Completed

Acupuncture for Sleep Disturbances in Post-Deployment Military Service Members

Sleep Disturbance

Japan
Zeria Pharmaceutical

Recruiting

A Phase III Trial of Z-338 in Paediatric Patients With Functional Dyspepsia

Functional Dyspepsia

Japan
Zeria Pharmaceutical

Completed

To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia

Functional Dyspepsia

Japan
Osaka City University

Completed

The Efficacy and Safety Study of Rikkunshito in Patients With Functional Dyspepsia

Functional Dyspepsia

Japan
Bayer

Completed

YAZ Post-marketing Surveillance in Japan

Dysmenorrhea

Japan
Astellas Pharma Inc

Completed

A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia

Functional Dyspepsia | Dyspepsia

Japan
Yakult Honsha Co., LTD
Japan Aerospace Exploration Agency

Active, not recruiting

Probiotics on Immune Function and Intestinal Microbiota in Astronauts Under Closed Microgravity Environment

Immune Function and Intestinal Microbiota

Japan
Zeria Pharmaceutical

Completed

The Effect of Z-338 in Subjects With Functional Dyspepsia

Functioanl Dyspepsia

Japan
Astellas Pharma Inc

Completed

Pharmacokinetics Study in Patients With Impaired Renal Function and Subjects With Normal Renal Function

Patients With Impaired Renal Function

Japan
Bayer

Completed

Survey on Menstrual Symptoms, Health Related Quality of Life and Work Productivity in Patients Suffering From Pain During Menstruation (Dysmenorrhea) in Japan

Dysmenorrhea

Japan
Astellas Pharma Inc

Completed

Pharmacokinetics Study in Patients With Impaired Hepatic Function

Patients With Impaired Hepatic Function

Japan
Astellas Pharma Inc

Completed

ASP8825 - Pharmacokinetics Study in Patients With Impaired Renal Function and Haemodialysis

Patients With Impaired Renal Function and Haemodialysis

Japan
Tohoku University

Unknown

Effect of Bifidobacterium on Irritable Bowel Syndrome (PBIBS)

Irritable Bowel Syndrome

Japan
Bayer

Completed

Drug Use Investigation (DUI) of YazFlex for Endometriosis-associated Pelvic Pain and/or Dysmenorrhea

Endometriosis and Dysmenorrhea

Japan
Bayer

Completed

Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea (J-MIRAI)

Menorrhagia, Dysmenorrhea

Japan
Astellas Pharma Inc

Completed

A Study to Evaluate Efficacy of Ramosetron on Diarrhea-predominant Irritable Bowel Syndrome (IBS) in Male Patients

Irritable Bowel Syndrome

Japan
Astellas Pharma Inc

Completed

A Study to Evaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female Patients

Irritable Bowel Syndrome

Japan
Astellas Pharma Inc

Completed

A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome

Irritable Bowel Syndrome

Japan
Bayer

Completed

Comparative Study of BAY86-5300 With a Flexible Extended Regimen for Dysmenorrhea

Dysmenorrhea

Japan
Astellas Pharma Inc

Completed

Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)

Irritable Bowel Syndrome

Japan
Astellas Pharma Inc

Completed

A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS)

Diarrhea-predominant Irritable Bowel Syndrome

Japan
Astellas Pharma Inc

Completed

A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome

Diarrhea-predominant Irritable Bowel Syndrome

Japan
Mie University

Completed

Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation

Adrenal Tumors

Japan
Astellas Pharma Inc

Completed

A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome

Constipation-predominant Irritable Bowel Syndrome (IBS-C)

Japan
Bayer

Completed

SH T00186 Phase II/ III Optimal Drospirenone (DRSP) Dose Finding and Placebo-controlled Comparative Study

Dysmenorrhea

Japan
Abbott Medical Devices

Completed

AVJ-514 Japan Trial

Mitral Valve Regurgitation | Mitral Valve Incompetence | Mitral Insufficiency | Functional Mitral Regurgitation | Mitral Stenosis With Insufficiency

Japan
Viveve Inc.

Completed

VIveve Treatment of the Vaginal Introitus to EValuate Effectiveness (VIVEVE I)

Vaginal Laxity Following Childbirth | Sexual Function Following Childbirth

Canada, Italy, Japan, Spain
Wakayama Medical University

Unknown

Combined Resection vs. Separated Resection After Mobilization of Splenic Vein During Distal Pancreatectomy (COSMOS-DP)

Pancreatic Neoplasms

Japan
National Hospital Organization Minami Kyoto Hospital

Recruiting

Sleep Hygiene, Sarcopenia, and Cognitive Function in Respiratory Disease

Sarcopenia | Cognitive Function | COPD | Sleep Hygiene | IPF

Japan
Osaka University

Recruiting

Targeted Alpha Therapy Using Astatine (At-211) Against Differentiated Thyroid Cancer

Thyroid Cancer

Japan
Invitae Corporation
National Cancer Center Hospital East

Recruiting

Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel (ARTEMIS-PC)

Pancreatic Cancer

Japan
Wakayama Medical University

Unknown

Phase I Study of Neoadjuvant Chemotherapy for Patients With Borderline Resectable Pancreatic Cancer.

Pancreatic Cancer

Japan
Novo Nordisk A/S

Completed

Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ryzodeg®

Diabetes

Japan
Osaka Medical Center for Cancer and Cardiovascular...

Completed

A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic Cancer

Pancreatic Cancer

Japan
Fukushima Medical University

Unknown

Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic Cancer

Pancreatic Cancer

Japan
Osaka Medical Center for Cancer and Cardiovascular...

Completed

Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer

Pancreatic Cancer

Japan
Japan Clinical Cancer Research Organization

Completed

GEM vs GEM+TS-1 for Advanced Pancreatic Cancer

Pancreatic Cancer

Japan
Fukushima Medical University
Human Genome Center, Institute of Medical Science, University of Tokyo

Unknown

Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer

Pancreatic Cancer

Japan
Fukushima Medical University
Human Genome Center, Institute of Medical Science, University of Tokyo

Unknown

HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1)

Pancreatic Cancer

Japan
Daiichi Sankyo Co., Ltd.

Completed

Study of CS-3150 in Patients With Primary Aldosteronism

Primary Aldosteronism

Japan
Novo Nordisk A/S

Completed

Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Japanese Subjects

Healthy | Diabetes

Japan
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)

Thyroid Neoplasms

Japan
Chiba University

Unknown

Additional Effects of Perioperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy

Pancreatic Tumor | Bile Duct Tumor

Japan
Fukushima Medical University
Human Genome Center, Institute of Medical Science, University of Tokyo

Completed

Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)

Pancreatic Cancer

Japan
Novo Nordisk A/S

Completed

Pharmacokinetics of Biphasic Insulin Aspart 50 and 70 in Japanese Healthy Volunteers

Healthy | Diabetes

Japan
Novo Nordisk A/S

Completed

Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) Preparations and Two Insulin Degludec (One Explorative) Preparations in Japanese Subjects

Healthy | Diabetes

Japan
Novo Nordisk A/S

Completed

Safety and Tolerability of Liraglutide in Healthy Japanese Volunteers

Healthy | Diabetes

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Multiple Oral Doses of PPM-204 in Healthy Japanese Male Subjects

Diabetes Mellitus

Japan
Hokkaido Gastrointestinal Cancer Study Group
Hokkaido University Hospital

Suspended

Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

Pancreatic Cancer

Japan

3

Subscribe